Hao Zhao

Active 1994–2027

Also published as
Hao ZHAO
533
Papers
33,010
Citations
73
h-index
309
i10-index

Citations

Citations per year for Hao Zhao1993: 1 citations1999: 1 citations2000: 1 citations2002: 3 citations2003: 1 citations2004: 4 citations2005: 3 citations2006: 5 citations2007: 25 citations2008: 28 citations2009: 56 citations2010: 48 citations2011: 61 citations2012: 62 citations2013: 68 citations2014: 58 citations2015: 85 citations2016: 118 citations2017: 179 citations2018: 275 citations2019: 538 citations2020: 916 citations2021: 1,245 citations2022: 1,261 citations2023: 1,234 citations2024: 2,003 citations2025: 1,820 citations2026: 501 citations1994–1998: no citations, so these years are not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,963 citing papers, 29% of this breakdownUnited States: 2,905 citing papers, 21.2% of this breakdownUnited Kingdom: 607 citing papers, 4.4% of this breakdownGermany: 536 citing papers, 3.9% of this breakdownFrance: 376 citing papers, 2.8% of this breakdownItaly: 351 citing papers, 2.6% of this breakdownAustralia: 339 citing papers, 2.5% of this breakdownCanada: 324 citing papers, 2.4% of this breakdownJapan: 277 citing papers, 2% of this breakdownSpain: 266 citing papers, 1.9% of this breakdownIndia: 260 citing papers, 1.9% of this breakdownSouth Korea: 254 citing papers, 1.9% of this breakdown
0%29%Other 23.5%

Fields

  • Medicine31.4%
  • Biochemistry, Genetics and Molecular Biology20%
  • Computer Science12.5%
  • Engineering10.7%
  • Immunology and Microbiology7.8%
  • Business, Management and Accounting5.3%
  • Other12.3%

Topics

  • Cancer Immunotherapy and Biomarkers6.7%
  • Immunotherapy and Immune Responses3.3%
  • Immune Cell Function and Interaction2.7%
  • Immune cells in cancer2.2%
  • CAR-T cell therapy research2.2%
  • Ferroptosis and cancer prognosis1.2%
  • Other81.7%

Coauthors

All papers

Open in search
  1. B cells and tertiary lymphoid structures promote immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 cited by 2,745

  2. Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

    Authors: , , , , , , , , , , , , , , , - Cell 2016 cited by 1,316

  3. CrossMap: a versatile tool for coordinate conversion between genome assemblies

    Authors: , , , , , - Bioinformatics, Bioinform. 2013 cited by 868

  4. TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice

    Authors: , , , , , , , , , , - Journal of Neuroinflammation 2020 cited by 364

  5. TLR4 signalling via Piezo1 engages and enhances the macrophage mediated host response during bacterial infection

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 267

  6. Glycogen accumulation and phase separation drives liver tumor initiation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2021 cited by 320

  7. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , - Nature Medicine 2017 cited by 592

  8. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine

    Authors: , , , , , , , - Cell Death Discovery 2024 cited by 248

  9. CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2023 cited by 97

  10. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 cited by 377

  11. Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation

    Authors: , , , , , , , - Frontiers in Endocrinology 2022 cited by 220

  12. Hi3DGen: High-fidelity 3D Geometry Generation from Images via Normal Bridging

    Authors: , , , , , , , - IEEE/CVF International Conference on Computer Vision (ICCV) 2025 cited by 59

  13. Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongling Huang, Yixin Chen, Bailong Xiao, Lilin Ye, Lanfen Chen, Dawang Zhou - Cell 2024 cited by 189

  14. Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 275

  15. OS-Harm: A Benchmark for Measuring Safety of Computer Use Agents

    Authors: , , , , , , - NeurIPS 2025 cited by 48

  16. Long Is More for Alignment: A Simple but Tough-to-Beat Baseline for Instruction Fine-Tuning

    Authors: , , , - ICML 2024 cited by 102

  17. DiffVLA: Vision-Language Guided Diffusion Planning for Autonomous Driving

    Authors: , , , , , , , , , , , , , - ArXiv.org, CoRR 2025 cited by 48

  18. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 327

  19. Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy

    Authors: , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 239

  20. SA-GS: Scale-Adaptive Gaussian Splatting for Training-Free Anti-Aliasing

    Authors: , , , , , , , - arXiv (Cornell University), CoRR 2024 cited by 38

  21. Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 241

  22. Impromptu VLA: Open Weights and Open Data for Driving Vision-Language-Action Models

    Authors: , , , , , , , , , , , , , , - NeurIPS 2025 cited by 58

  23. UniScene: Unified Occupancy-centric Driving Scene Generation

    Authors: , , , , , , , , , , , , , , , , - IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2025 cited by 36

  24. DriveMLLM: A Benchmark for Spatial Understanding with Multimodal Large Language Models in Autonomous Driving

    Authors: , , , , , , , , , - NeurIPS 2025 cited by 34